Trial Profile
Changes in retinal microcirculation after intravitreal aflibercept in eyes with macular edema secondory to branch retinal vein occlusion
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Aug 2017
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Branch retinal vein occlusion; Retinal oedema
- Focus Pharmacodynamics
- 01 Aug 2017 New trial record